Mathematical and experimental analysis of localization of anti-tumour antibody–enzyme conjugates

SummaryConsiderable research has been aimed at improving the efficacy of chemotherapeutic agents for cancer therapy. A promising two-step approach that is designed to minimize systemic drug toxicity while maximizing activity in tumours employs monoclonal antibody (mAb)–enzyme conjugates for the activation of anticancer prodrugs. We present, analyse and numerically simulate a mathematical model based on the biology of the system to study the biodistribution, pharmacokinetics and localization properties of mAb–enzyme conjugates in tumour tissue. The model predictions were compared with experimental observations and an excellent correlation was found to exist. In addition, the critical parameters affecting conjugate half-life were determined to be the inter-capillary half-distance and the antibody–antigen binding affinity. An approximation is presented relating the per cent injected dose per gram to inter-capillary half-distance and time. Finally, the model was used to examine various dosing strategies in an attempt to determine which regimen would provide the best biodistribution results. We compared the results of administering a uniform dose of fusion protein via bolus injection, multiple injections and continuous infusion. The model predicts that dosing strategy has little effect on the amount of conjugate that localizes in the tumour.

• Publication year

  1999

• Venue

  British Journal of Cancer

• Publication date

  1999-08-01

• Fields of study

  Biology, Mathematics, Medicine

• Identifiers
  DOI 10.1038/sj.bjc.6690592PMID 10468291PMCID 2363130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation.

  1997influential reference
• Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data.

  1996influential reference
• Antibody-enzyme conjugates for cancer therapy.

  1996influential reference
• First clinical experience with ADEPT

  1996cited by this paper
• A summary of monoclonal antibody-enzyme/prodrug

  1996influential reference
• In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.

  1995cited by this paper
• Antibody-Directed Enzyme Prodrug Therapy (ADEPT): A Targeting Strategy in Cancer Chemotherapy

  1995cited by this paper
• Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.

  1995cited by this paper
• Tumor-selective prodrug activation by fusion protein-mediated catalysis.

  1994influential reference
• Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.

  1994cited by this paper
• Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.

  1994influential reference
• Chemoimmunoconjugates for the treatment of cancer.

  1994cited by this paper
• Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.

  1993cited by this paper
• Generation of cytotoxic agents by targeted enzymes.

  1993cited by this paper
• Pharmacokinetic analysis of the perivascular distribution of bifunctional antibodies and haptens: comparison with experimental data.

  1992cited by this paper
• Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism.

  1991cited by this paper
• Transport of fluid and macromolecules in tumors. IV. A microscopic model of the perivascular distribution.

  1991cited by this paper
• Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism.

  1991cited by this paper
• Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds.

  1991cited by this paper
• Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection.

  1989cited by this paper
• Microvascular permeability of normal and neoplastic tissues.

  1986cited by this paper
• Extravascular diffusion in normal and neoplastic tissues.

  1984cited by this paper
• Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin Substrate

  1972cited by this paper
• The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue

  1919cited by this paper

• Numerical and statistical approach on chemotaxis-haptotaxis model for cancer cell invasion of tissue

  2024cites this paper
• Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for Efficacy

  2016cites this paper
• Modeling Dynamic Fluctuations in Type 1 Diabetes Progression: Quantifying β -cell variation after the appearance of islet-specific autoimmune responses

  2015cites this paper
• A mechanistic compartmental model for total antibody uptake in tumors.

  2012cites this paper
• A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

  2009cites this paper
• Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses.

  2009cites this paper
• Mathematical Modelling of Proteolysis and Cancer Cell Invasion of Tissue

  2006cites this paper
• Mathematical modelling of cancer cell invasion of tissue

  2005cites this paper
• On the mechanochemical theory of biological pattern formation with application to vasculogenesis.

  2003cites this paper
• Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.

  2001cites this paper
• Biological Pattern Formation — A Marriage of Theory and Experiment

  2001cites this paper
• Development and validation of a mathematical model to describe anti-cancer prodrug activation by antibody-Enzyme conjugates

  2000cites this paper
• A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.

  2000cites this paper
• Pattern formation in integrative biology--a marriage of theory and experiment.

  2000cites this paper
• Theoretical analysis of conjugate localization in two-step cancer chemotherapy

  1999cites this paper